United States · Series B startup

Who invested in Vyriad

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $25MDec 2025
Investors
1
See who backed them

The rounds

  1. Dec 2025
    Series B$25M

    Source recorded

Founders and team

From the SEC filings it signed: 5 on the team.

  • Alice S. BexonExecutive Officeri
  • Glen N. BarberDirector, Promoteri
  • James J. HannonExecutive Officeri
  • Kah-Whye S. PengExecutive Officeri
  • Stephen J. RussellExecutive Officer, Director, Promoteri

On the board, as filediAhryon N. ChoAndrew N. KhooEdwin M. KaniaNathan L. Stacy

Everyone who backed them

Mayo ClinicInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Vyriad as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Southeast Minnesota Capital Fund LLCAngel networkPer its own site

Quick answers about Vyriad

Who invested in Vyriad?

Vyriad's investors include Mayo Clinic.

How much has Vyriad raised?

Vyriad has raised $25M across 1 round since 2025.

When did Vyriad last raise?

Vyriad's most recent round was a Series B of $25M in Dec 2025.

What was Vyriad's biggest round?

Its most recent round, $25M in Dec 2025, is also its largest on record.

Who backed Vyriad first?

Vyriad's first round on record, in Dec 2025, was backed by Mayo Clinic.

What stage is Vyriad at?

Vyriad's latest named round is a Series B, in Dec 2025.

Where is Vyriad based?

Vyriad is based in the United States.

Companies like Vyriad

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.